Amgen

Open: 323.64 Close: 323.11 Change: -0.53

Our AI found unexpected things about Amgen Stock.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, result, fourth, quarter, full, year, financial, and the most common words in the summary are: amgen, stock, market, top, amgn, invest, price, . One of the sentences in the summary was: Amgen expected to beat expectations when it reports fourth-quarter and full-year 2023 results on …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen expected to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 6, after market close. U.S. Supreme Court will review Section 112 of the Patent Act for the second time in the history.

Today's News

Amgen announces webcast of 2023 fourth quarter and full year financial results. Increases land position at Maitamac project, Colombia. Amgen announces webcast of 2023 fourth quarter and full year financial results. Amgen will report fourth quarter, full year 2023 financial results on February 6, 2024. Amgen is a leader in biotechnology-based human therapeutics. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019) Amgen Inc. (AMGN) NASDAQ: AMGN · IEX Real-Time Price · USD Add to Watchlist 322.62 -1.94 (-0.60%) Amgen is expected to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 6, after market close. Amgen closed the previously announced acquisition of Horizon Therapeutics. U.S. Supreme Court will review Section 112 of the Patent Act for the second time in the history. Amgen is letting go of 350 employees following its acquisition of Horizon Therapeutics. Amgen laying off approximately 300 team members to “better manage against industry headwinds” The job cuts will mainly affect Amgens commercial team and will involve employees based in the U.S. Amgen (NASDAQ:AMGN) is $ 323 last updated Today at February 2, 2024 at 1:43 PM EST. Amgen is in the Health Care sector and Biotechnology industry. The next Amgen dividend date is projected to be February 15, 2024.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, result, fourth, quarter, full, year, financial, and the most common words in the summary are: amgen, stock, market, top, amgn, invest, price, . One of the sentences in the summary was: Amgen expected to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 6, after market close. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #top #amgn #invest #price.